Matthew Scalo

Matthew Scalo

Investor Relations Contact chez MYRIAD GENETICS, INC.

Finance
Health Technology
Consumer Services

Profil

Matthew Scalo is currently a Senior Vice President & Investor Relations at Myriad Genetics, Inc. He previously worked as a Senior Director-Investor Relations at Luminex Corp., Investor Relations Contact at NextGen Healthcare, Inc., Senior Research Analyst at Allspring Global Investments LLC, Research Analyst at Canaccord Adams, Inc., VP, Investor Relations & Corporate Development at Cutera, Inc., and Associate at Broadpoint.
Gleacher Securities.
He also worked as a Research Analyst at Canaccord Genuity, Inc. Mr. Scalo holds an MBA degree from the University of Notre Dame and an undergraduate degree from the University of California, Davis.

Postes actifs de Matthew Scalo

SociétésPosteDébut
MYRIAD GENETICS, INC. Investor Relations Contact 01/08/2022
Tous les postes actifs de Matthew Scalo

Anciens postes connus de Matthew Scalo

SociétésPosteFin
Analyst-Equity 31/12/2010
Analyst-Equity 22/04/2010
Analyst-Equity 31/12/2003
Analyst-Equity 31/12/2002
NEXTGEN HEALTHCARE, INC. Investor Relations Contact -
Voir l'expérience en détail de Matthew Scalo

Formation de Matthew Scalo

University of Notre Dame Masters Business Admin
University of California, Davis Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Matthew Scalo

Relations

100 +

Relations au 1er degré

10

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
MYRIAD GENETICS, INC.

Health Technology

CUTERA, INC.

Health Technology

Entreprise privées6

Technology Services

Finance

Health Technology

Finance

Finance

Finance

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Matthew Scalo